CJC-1295 (without DAC) and Rapamycin Interaction

Monitor
Mechanism-based 47% confidence

CJC-1295 (without DAC) and Rapamycin have an interaction requiring monitoring for interaction with 47% confidence. Both CJC-1295 (without DAC) and Rapamycin affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). These compounds primarily affect different organ systems.

Compound Profiles

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Half-life: 30 minutes - 2 hours Typical dose: 100-300mcg per injection growth hormone, weight loss
ghrh receptor carcinogenic riskestrogenicinsulin disruptingteratogenic
View full profile

Rapamycin

mTOR Inhibitor | Longevity & Immunosuppression

Rapamycin exerts its effects by binding to the intracellular protein FKBP12, forming a complex that directly and specifically inhibits mechanistic target of rapamycin complex 1 (mTORC1). mTORC1 is a master nutrient-sensing kinase that integrates signals from growth factors, amino acids, energy status, and stress to regulate cell growth, proliferation, and metabolism.

Half-life: ~62 hours Typical dose: 3-6 mg once weekly (longevity protocol) longevity, immune
mtor immunosuppressiveinsulin disruptinglipid disruptingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low

Shared Safety Flags

2x 2 compounds affect insulin sensitivity (CJC-1295 (without DAC), Rapamycin). Monitor fasting glucose and HbA1c.
2x 2 compounds share the teratogenic safety flag (CJC-1295 (without DAC), Rapamycin). Monitor accordingly.

Frequently Asked Questions

Can I take CJC-1295 (without DAC) with Rapamycin?

Yes, but with caution. Both CJC-1295 (without DAC) and Rapamycin affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Regular monitoring is advised.

Is CJC-1295 (without DAC) and Rapamycin safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: insulin disrupting, teratogenic. Monitor accordingly.

What are the interactions between CJC-1295 (without DAC) and Rapamycin?

Both CJC-1295 (without DAC) and Rapamycin affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time CJC-1295 (without DAC) and Rapamycin?

CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and Rapamycin has a half-life of ~62 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 (without DAC) vs Rapamycin

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.